143 related articles for article (PubMed ID: 34055985)
21. Intrinsic function of the peptidylarginine deiminase PADI4 is dispensable for normal haematopoiesis.
Young C; Russell JR; Van De Lagemaat LN; Lawson H; Mapperley C; Kranc KR; Christophorou MA
Biol Open; 2022 Jun; 11(6):. PubMed ID: 35603697
[TBL] [Abstract][Full Text] [Related]
22. The role of peptidylarginine deiminase 4 in ovarian cancer cell tumorigenesis and invasion.
Cui YY; Yan L; Zhou J; Zhao S; Zheng YB; Sun BH; Lv HT; Rong FN; Chang XT
Tumour Biol; 2016 Apr; 37(4):5375-83. PubMed ID: 26563365
[TBL] [Abstract][Full Text] [Related]
23. The Prominent Role of Hematopoietic Peptidyl Arginine Deiminase 4 in Arthritis: Collagen- and Granulocyte Colony-Stimulating Factor-Induced Arthritis Model in C57BL/6 Mice.
Fukui S; Gutch S; Fukui S; Cherpokova D; Aymonnier K; Sheehy CE; Chu L; Wagner DD
Arthritis Rheumatol; 2022 Jul; 74(7):1139-1146. PubMed ID: 35166055
[TBL] [Abstract][Full Text] [Related]
24. Sulforaphene inhibits the progression of osteosarcoma via regulating FSTL1/NF-κB pathway.
Zhang G; Jin C; Zhu Y; Fu F; Wang G; Li S
Life Sci; 2020 Dec; 263():118485. PubMed ID: 33017573
[TBL] [Abstract][Full Text] [Related]
25. Regulatory effects of microRNA‑184 on osteosarcoma via the Wnt/β‑catenin signaling pathway.
Du Z; Li F; Wang L; Huang H; Xu S
Mol Med Rep; 2018 Aug; 18(2):1917-1924. PubMed ID: 29916553
[TBL] [Abstract][Full Text] [Related]
26. Dioscin inhibits stem-cell-like properties and tumor growth of osteosarcoma through Akt/GSK3/β-catenin signaling pathway.
Liu W; Zhao Z; Wang Y; Li W; Su Q; Jia Q; Zhang J; Zhang X; Shen J; Yin J
Cell Death Dis; 2018 Mar; 9(3):343. PubMed ID: 29497056
[TBL] [Abstract][Full Text] [Related]
27. Biochemical and biophysical characterization of PADI4 supports its involvement in cancer.
Neira JL; Araujo-Abad S; Cámara-Artigas A; Rizzuti B; Abian O; Giudici AM; Velazquez-Campoy A; de Juan Romero C
Arch Biochem Biophys; 2022 Mar; 717():109125. PubMed ID: 35081374
[TBL] [Abstract][Full Text] [Related]
28. Suppression of adriamycin resistance in osteosarcoma by blocking Wnt/β-catenin signal pathway.
Wu BQ; Cao Y; Bi ZG
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3185-3192. PubMed ID: 28770967
[TBL] [Abstract][Full Text] [Related]
29. Down-regulation of long non-coding RNA ITGB2-AS1 inhibits osteosarcoma proliferation and metastasis by repressing Wnt/β-catenin signalling and predicts favourable prognosis.
Dai J; Xu LJ; Han GD; Jiang HT; Sun HL; Zhu GT; Tang XM
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S783-S790. PubMed ID: 30260245
[TBL] [Abstract][Full Text] [Related]
30. Dihydroartemisinin inhibits tumor growth of human osteosarcoma cells by suppressing Wnt/β-catenin signaling.
Liu Y; Wang W; Xu J; Li L; Dong Q; Shi Q; Zuo G; Zhou L; Weng Y; Tang M; He T; Luo J
Oncol Rep; 2013 Oct; 30(4):1723-30. PubMed ID: 23917613
[TBL] [Abstract][Full Text] [Related]
31. Silencing Transmembrane Protein 45B (TNEM45B) Inhibits Proliferation, Invasion, and Tumorigenesis in Osteosarcoma Cells.
Li Y; Guo W; Liu S; Zhang B; Yu BB; Yang B; Kan SL; Feng SQ
Oncol Res; 2017 Jul; 25(6):1021-1026. PubMed ID: 28244852
[TBL] [Abstract][Full Text] [Related]
32. Inactive Wnt/beta-catenin pathway in conventional high-grade osteosarcoma.
Cai Y; Mohseny AB; Karperien M; Hogendoorn PC; Zhou G; Cleton-Jansen AM
J Pathol; 2010 Jan; 220(1):24-33. PubMed ID: 19882675
[TBL] [Abstract][Full Text] [Related]
33. KIAA1429 promotes osteosarcoma progression by promoting stem cell properties and is regulated by miR-143-3p.
Han Q; Yang J; Yang H; Li C; Li J; Cao Y
Cell Cycle; 2020 May; 19(10):1172-1185. PubMed ID: 32286148
[No Abstract] [Full Text] [Related]
34. MicroRNA-340-5p suppresses osteosarcoma development by down-regulating the Wnt/β-catenin signaling pathway via targeting the STAT3 gene.
Rongxin S; Pengfei L; Li S; Xiaochen J; Yihe H
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):982-991. PubMed ID: 30779064
[TBL] [Abstract][Full Text] [Related]
35. Increased PADI4 expression in blood and tissues of patients with malignant tumors.
Chang X; Han J; Pang L; Zhao Y; Yang Y; Shen Z
BMC Cancer; 2009 Jan; 9():40. PubMed ID: 19183436
[TBL] [Abstract][Full Text] [Related]
36. Wnt signaling in osteosarcoma.
Lin CH; Ji T; Chen CF; Hoang BH
Adv Exp Med Biol; 2014; 804():33-45. PubMed ID: 24924167
[TBL] [Abstract][Full Text] [Related]
37. SPARCL1 suppresses osteosarcoma metastasis and recruits macrophages by activation of canonical WNT/β-catenin signaling through stabilization of the WNT-receptor complex.
Zhao SJ; Jiang YQ; Xu NW; Li Q; Zhang Q; Wang SY; Li J; Wang YH; Zhang YL; Jiang SH; Wang YJ; Huang YJ; Zhang XX; Tian GA; Zhang CC; Lv YY; Dai M; Liu F; Zhang R; Zhou D; Zhang ZG
Oncogene; 2018 Feb; 37(8):1049-1061. PubMed ID: 29084211
[TBL] [Abstract][Full Text] [Related]
38. [Expression of Ether à go-go 1 and its molecular mechanism of regulating the malignant phenotype of osteosarcoma].
Chen ZD; Liu QJ; Zeng WR; Wu XY; Lin B; Wu J
Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):818-825. PubMed ID: 27998439
[No Abstract] [Full Text] [Related]
39. PADI4 has genetic susceptibility to gastric carcinoma and upregulates CXCR2, KRT14 and TNF-α expression levels.
Zheng Y; Zhao G; Xu B; Liu C; Li C; Zhang X; Chang X
Oncotarget; 2016 Sep; 7(38):62159-62176. PubMed ID: 27556695
[TBL] [Abstract][Full Text] [Related]
40. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling.
Chen J; Liu G; Wu Y; Ma J; Wu H; Xie Z; Chen S; Yang Y; Wang S; Shen P; Fang Y; Fan S; Shen S; Fang X
Mol Cancer; 2019 Oct; 18(1):150. PubMed ID: 31665067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]